Beyond TREM2, we have found that protective variants in MS4A6A and PLCG2 gene expression also decrease P2Y12 and P2Y13 receptor expression (unpublished data), suggesting that this mechanism of microglial activation could be common across several microglial AD risk loci. This evidence concerns the gene TREM2 and Alzheimer disease.